hotspot -WSS

hotspot

author：fashion 2025-08-04 12:36:03 - browse：9

Andrew Witty, Chief Executive Officer of UnitedHealth Group, testifies at a Senate Finance Committee hearing examining cyber attacks.-- health tech coverage from STAT — UnitedHealth Group CEO Andrew Witty said the company was beginning to see a “disturbance” in its Medicaid medical costs. Jacquelyn Martin/AP

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

What’s next for Risant?

Kaiser Permanente grabbed everyone’s attention last year when it said it was creating Risant Health, a new and vague entity that acquired Geisinger and had plans to scoop up at least four more health systems that are focused on “value-based care.”

Well, nothing has happened since then, at least publicly. Instead, everyone has been playing the parlor game of guessing who those next systems could be. There are some rumblings that the next deal could be announced in the near future. After reading some recent hospital financial reports, it’s clear there are a handful of systems that mirror Geisinger’s shaky trajectory and could find themselves in Kaiser’s crosshairs.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： How the Dana

WSS

WHO recommends dropping component of many flu vaccines

FDA advisers vote against ALS treatment from BrainStorm

How one patient went off dialysis — and others can too

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Would Medicare drug price negotiations stall in a shutdown?

Data show record exodus of life scientists from academia

knowledge

hotspot

What’s next for Risant?

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Duchenne breakthrough therapy leaves behind pioneering families

Biogen shutters digital health group, ends Apple study, in cost cutting move

BioMarin wins approval for gene therapy to treat hemophilia A

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

State Dept. review finds Biden bears some blame for Afghanistan failures

U.S. death rates show how politics are affecting public health

Supreme Court strikes down use of affirmative action

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

DIEP, the 'gold standard' of breast reconstruction, is under threat

Listen: Who gets the credit for GLP

focus

J&J reports mixed data on next

Health tech startups drop sharply from 2021 highs

Paxlovid should be available without a positive Covid test

J&J reports mixed data on next

Kaiser Permanente unions announce official strike date

Some medical students still think black patients feel less pain

Wikipedia

hotspot

knowledge

entertainment